BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27793901)

  • 1. In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized Protocol.
    Baert T; Garg AD; Vindevogel E; VAN Hoylandt A; Verbist G; Agostinis P; Vergote I; Coosemans AN
    Anticancer Res; 2016 Nov; 36(11):5793-5801. PubMed ID: 27793901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic combination of murine bone marrow-derived dendritic cells loaded ex vivo with whole tumor lysate and systemic chemotherapy mediates antitumor immune responses in vivo.
    Salem ML; Nassef M; Gomaa S; Essa I
    Biomed Pharmacother; 2017 Sep; 93():286-295. PubMed ID: 28648976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
    Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
    Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.
    den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Frielink C; Toonen LW; Boerman OC; Figdor CG; Ruers TJ; Adema GJ
    Br J Cancer; 2006 Oct; 95(7):896-905. PubMed ID: 16953240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer.
    Vindevogel E; Baert T; VAN Hoylandt A; Verbist G; Vande Velde G; Garg AD; Agostinis P; Vergote I; Coosemans AN
    Anticancer Res; 2016 Nov; 36(11):5781-5792. PubMed ID: 27793900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Unveiling antigens in a non-immunogenic spontaneous murine tumor using a dendritic cell based vaccine].
    Reffo VL; Chiarella P; Bruzzo J; Bustuoabad OD; Ruggiero RA
    Medicina (B Aires); 2008; 68(4):301-4. PubMed ID: 18786887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines.
    Liu Z; Fan H; Wu Y; Chen B
    Cytotherapy; 2005; 7(4):353-62. PubMed ID: 16162457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.
    Labeur MS; Roters B; Pers B; Mehling A; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1999 Jan; 162(1):168-75. PubMed ID: 9886383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model.
    Pilon-Thomas S; Li W; Briggs JJ; Djeu J; Mulé JJ; Riker AI
    J Immunother; 2006; 29(4):381-7. PubMed ID: 16799333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased survival and decreased tumor size due to intratumoral injection of ethanol followed by administration of immature dendritic cells.
    Kumagi T; Akbar SM; Horiike N; Onji M
    Int J Oncol; 2003 Oct; 23(4):949-55. PubMed ID: 12963973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy.
    Saji H; Song W; Furumoto K; Kato H; Engleman EG
    Clin Cancer Res; 2006 Apr; 12(8):2568-74. PubMed ID: 16638867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
    Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
    Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice.
    Gu X; Erb U; Büchler MW; Zöller M
    Int J Cancer; 2015 Feb; 136(4):E74-84. PubMed ID: 25066479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.
    Kao JY; Zhang M; Chen CM; Pierzchala A; Chen JJ
    Immunol Lett; 2006 May; 105(1):16-25. PubMed ID: 16388858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity.
    Curiel-Lewandrowski C; Mahnke K; Labeur M; Roters B; Schmidt W; Granstein RD; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1999 Jul; 163(1):174-83. PubMed ID: 10384114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors.
    Jung NC; Kim HJ; Kang MS; Lee JH; Song JY; Seo HG; Bae YS; Lim DS
    Cancer Lett; 2012 Nov; 324(1):58-65. PubMed ID: 22554711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-tumor immune response of dendritic cells transfected with wild-type p53 gene].
    Liu HJ; Xin JB; Li ZY; Xiong XZ; Tao XN; Hu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):902-7. PubMed ID: 19134406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G1-4 A, an arabinogalactan polysaccharide from Tinospora cordifolia increases dendritic cell immunogenicity in a murine lymphoma model.
    Pandey VK; Shankar BS; Sainis KB
    Int Immunopharmacol; 2012 Dec; 14(4):641-9. PubMed ID: 23079132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.